Glutathione should not be taken by children, pets, those who are pregnant or breastfeeding, or those who are allergic to any of the ingredients in glutathione
Its also beneficial for those exposed to pollution or leading stressful lifestyles that may accelerate oxidative stress and aging
Author contributions SK: Writing review & editing, Investigation, Supervision, Writing original draft, Formal analysis, Conceptualization, Validation, Project administration, Methodology, Visualization
Oral VK2735 (Viking Therapeutics) -- Phase 2# VK2735 is unique as the only dual GLP-1/GIP agonist with an oral formulation in clinical development: 12.2% weight loss at 13 weeks (oral tablet) 97% of treatment groups achieved at least 5% weight loss Oral Phase 3 expected Q3 2026 The injectable SC formulation achieved 14.7% at 13 weeks Oral Amycretin (Novo Nordisk) -- Phase 1# Novo Nordisk's oral amycretin demonstrated 13.1% weight loss at just 12 weeks, the highest early-stage oral result